Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-03 Purchase | 2019-07-08 9:32 pm | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 882,353 | $29.9 | $26,382,796 | 24,575,501 (Indirect) | View |
| 2019-05-24 Purchase | 2019-05-29 7:17 pm | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 1,103,848 | $25.93 | $28,622,779 | 23,693,148 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-21 Option Award | 2023-06-23 4:23 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:34 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 104,921 | $0 | 104,921 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 8:00 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 38,895 | $0 | 38,895 (Direct) | View |
Ownership | 2021-04-22 7:12 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Satvat Ali J. Director | 0 | $0 | 0 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-28 8:40 pm | N/A 2030-05-27 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 159,404 | $0 | 159,404 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:08 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director | 86,112 | $0 | 0 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-04 7:17 pm | N/A 2030-06-01 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director 10% Owner | 112,422 | $0 | 112,422 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:05 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-01-10 Option Award | 2020-01-14 5:55 pm | N/A 2030-01-10 | Coherus BioSciences Inc. | CHRS | Satvat Ali J. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 8:56 pm | N/A 2029-12-11 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director 10% Owner | 82,878 | $0 | 82,878 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-13 9:25 pm | N/A 2029-06-11 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 21,528 | $0 | 21,528 (Direct) | View |